Hybrid vector designs to control the delivery, fate and expression of transgenes.
One of the greatest challenges to gene therapy is the targetting of gene delivery selectively to the sites of disease and regulation of transgene expression without adverse effects. Ultimately, the successful realization of these goals is dependent upon improvements in vector design. Over the years, viral vector design has progressed from various types of replication-defective viral mutants to replication-conditioned viruses and, more recently, to 'gutted' and hybrid vectors, which have, respectively, eliminated expression of non-relevant or toxic viral genes and incorporated desired elements of different viruses so as to increase the efficacy of gene delivery in vivo. This review will focus on the different viral and cellular elements which have been incorporated into virus vectors to: improve transduction efficiencies; alter the entry specificity of virions; control the fate of transgenes in the host cells; and regulate transgene expression.
Lam
P Y
PY
Massachusetts General Hospital, and Department of Neurology, Harvard Medical School, Boston 02114, USA.
Breakefield
X O
XO
D000818:Animals; D004274:DNA, Recombinant; D005786:Gene Expression Regulation; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000235:genetics*; D006801:Humans; D019076:Transgenes / Q000235:genetics*; D014780:Viruses / Q000235:genetics
D004274:DNA, Recombinant